Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis
Publikation: Bidrag til tidsskrift › Leder › Forskning
Standard
Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs : The proof of concept in early myelofibrosis. / Hasselbalch, Hans Carl.
I: Cancer, Bind 123, Nr. 14, 2017, s. 2600-2603.Publikation: Bidrag til tidsskrift › Leder › Forskning
Harvard
Hasselbalch, HC 2017, 'Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis', Cancer, bind 123, nr. 14, s. 2600-2603. https://doi.org/10.1002/cncr.30676
APA
Hasselbalch, H. C. (2017). Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis. Cancer, 123(14), 2600-2603. https://doi.org/10.1002/cncr.30676
Vancouver
Hasselbalch HC. Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis. Cancer. 2017;123(14):2600-2603. https://doi.org/10.1002/cncr.30676
Author
Bibtex
@article{fa573b43671d4fe6ac1d52b6c5cdcf7e,
title = "Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis",
author = "Hasselbalch, {Hans Carl}",
year = "2017",
doi = "10.1002/cncr.30676",
language = "English",
volume = "123",
pages = "2600--2603",
journal = "Cancer",
issn = "0008-543X",
publisher = "JohnWiley & Sons, Inc.",
number = "14",
}
RIS
TY - JOUR
T1 - Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs
T2 - The proof of concept in early myelofibrosis
AU - Hasselbalch, Hans Carl
PY - 2017
Y1 - 2017
U2 - 10.1002/cncr.30676
DO - 10.1002/cncr.30676
M3 - Editorial
C2 - 28518284
VL - 123
SP - 2600
EP - 2603
JO - Cancer
JF - Cancer
SN - 0008-543X
IS - 14
ER -
ID: 195590129